Pharmaron Beijing Co., Ltd. (SZSE:300759) intends to acquire Beijing AnniKeeper Biotechnology Co., Ltd from Chen Jing and Chen Xuejun for approximately RMB 85.2 million on March 25, 2022. After the completion of this transaction, the company will hold 100% of the equity of Beijing AnniKeeper Biotechnology Co., Ltd. The consideration will be funded from own funds. As of December 31, 2021, Beijing AnniKeeper reported RMB 15.5 million total assets, RMB 5.5 million operating profit, RMB 4.8 million net profit. The transaction has been approved by the board of Pharmaron Beijing Co., at meeting held on March 25, 2022.